Inaugural Psychiatry Summit 2022

Download All
Access timely, unbiased, evidence-based, continuing education on the latest advances in psychiatry today, including bipolar depression and disorders, tardive dyskinesia, attentional complaints, psychopharmacology, anxiety disorders, digital tools, and schizophrenia. Review downloadable slides, program documents, and on-demand webcasts from Psychiatry Summit 2022 that cover advances in the diagnosis and treatment of a wide range of psychiatric illnesses.
Jonathan M. Meyer, MD

New Mechanisms, New Medications for Schizophrenia

This presentation reviews the evidence showing antipsychotic properties can be conferred by agents that do not bind to D2 receptors; the preclinical and clinical evidence underlying the antipsychotic mechanisms underlying 5-HT2A antagonism, muscarinic M4 agonism, and TAAR1 agonism; and how TAAR1 agonists modulate activity at presynaptic and postsynaptic D2 receptors via a G-protein independent pathway (Akt/β-arrestin2/glycogen synthase kinase 3β).

Jonathan M. Meyer, MD Released: March 22, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

 
Independent Educational Activity

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings